Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Messina

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Headache and Pain|December 19, 2021
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort studyFabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.
Neurology and Therapy|June 20, 2025
From Headache to Heart Health: Investigating the Migraine-Cardiovascular Disease ConnectionClaudio Tana, Dilara Onan, Roberta Messina, et al.
Nature Reviews. Disease Primers|March 26, 2021
Tension-type headacheSait Ashina, Dimos D Mitsikostas, Mi Ji Lee, et al.
Journal of Neurology|March 22, 2015
Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutationsMaria A Rocca, Stefania Bianchi-Marzoli, Roberta Messina, et al.
Scientific Reports|September 7, 2017
Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patientsEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.
International Journal of Cardiology. Heart & Vasculature|September 9, 2020
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularizationEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.
Journal of Neurology|August 7, 2023
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
The Journal of Headache and Pain|December 5, 2024
Combining treatments for migraine prophylaxis: the state-of-the-artLanfranco Pellesi, David Garcia-Azorin, Eloisa Rubio-Beltrán, et al.
The Journal of Headache and Pain|April 4, 2025
Correction: Combining treatments for migraine prophylaxis: the state‑of‑the‑artLanfranco Pellesi, David Garcia-Azorin, Eloisa Rubio-Beltrán, et al.
Journal of Neurology|January 25, 2025
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE studyPiero Barbanti, Cinzia Aurilia, Paola Torelli, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Headache and Pain|December 19, 2021
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort studyFabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.
Neurology and Therapy|June 20, 2025
From Headache to Heart Health: Investigating the Migraine-Cardiovascular Disease ConnectionClaudio Tana, Dilara Onan, Roberta Messina, et al.
Nature Reviews. Disease Primers|March 26, 2021
Tension-type headacheSait Ashina, Dimos D Mitsikostas, Mi Ji Lee, et al.
Journal of Neurology|March 22, 2015
Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutationsMaria A Rocca, Stefania Bianchi-Marzoli, Roberta Messina, et al.
Scientific Reports|September 7, 2017
Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patientsEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.
International Journal of Cardiology. Heart & Vasculature|September 9, 2020
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularizationEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.
Journal of Neurology|August 7, 2023
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
The Journal of Headache and Pain|December 5, 2024
Combining treatments for migraine prophylaxis: the state-of-the-artLanfranco Pellesi, David Garcia-Azorin, Eloisa Rubio-Beltrán, et al.
The Journal of Headache and Pain|April 4, 2025
Correction: Combining treatments for migraine prophylaxis: the state‑of‑the‑artLanfranco Pellesi, David Garcia-Azorin, Eloisa Rubio-Beltrán, et al.
Journal of Neurology|January 25, 2025
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE studyPiero Barbanti, Cinzia Aurilia, Paola Torelli, et al.
Pageof 8